Ceftazidime-avibactam susceptibility among KPC-producing enterobacterales in southern Brazil

Ceftazidime-avibactam susceptibility among KPC-producing enterobacterales in southern Brazil

Carbapenem-resistant Enterobacterales (CRE) are a subject of global concern as limited therapeutic options are available. New combinations of β-lactams and β-lactamase inhibitors, such as ceftazidime-avibactam (CAZ-AVI), have recently been approved in Brazil for the treatment of CRE infections. Cas...

Full description

Bibliographic Details
Main Authors: Natália Kehl Moreira, Gabriela da Silva Collar, Priscila Lamb Wink, Afonso Luís Barth, Juliana Caierão
Format: Article
Language:English
Published: Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS) 2023-11-01
Series:Clinical and Biomedical Research
Subjects:
Ceftazidime-avibactam
Enterobacterales
Carbapenemase
Resistance
Online Access:https://seer.ufrgs.br/index.php/hcpa/article/view/128523

Similar Items

Similar Items